drugset / Trial / NCT04234321
Clinical Study of Kangfuxin and Basic Fibroblast Growth Factor in Promoting the Healing of Donor Site
Unknown
300 enrolled
Second Affiliated Hospital, School of Medicine, Zhejiang University
Jiangyin Hospital Affiliated to Southeast University School of Medicine · collabLishui Country People's Hospital · collabNantong University · collabTaizhou Hospital · collabThe 59th Central Hospital of the Chinese people's Liberation Army · collabThe Second Affiliated Hospital of Kunming Medical University · collabZhejiang Quhua Hospital · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The main objective of this study is to observe whether basic fibroblast growth factor and Kangfuxin Liquid can promote the wound healing in the donor area and further evaluate the healing quality.
Timeline
- Start
- 2020-08-01
- Primary completion
- 2022-06-30
- Completion
- 2022-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BASIC FIBROBLAST GROWTH FACTOR (HUMAN) | Protein / enzyme biologic | 35000 iu | — |
| Subject | Kangfuxin Liquid | Unknown | 20 ml | — |
Indications
No indication recorded.